1. Home
  2. MEG vs ARVN Comparison

MEG vs ARVN Comparison

Compare MEG & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$26.72

Market Cap

904.3M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$12.57

Market Cap

806.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
ARVN
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
904.3M
806.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MEG
ARVN
Price
$26.72
$12.57
Analyst Decision
Buy
Buy
Analyst Count
4
23
Target Price
$33.50
$17.80
AVG Volume (30 Days)
331.8K
2.3M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$826,323,000.00
$312,300,000.00
Revenue This Year
$19.70
$11.06
Revenue Next Year
$2.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.77
93.86
52 Week Low
$10.51
$5.90
52 Week High
$32.00
$22.48

Technical Indicators

Market Signals
Indicator
MEG
ARVN
Relative Strength Index (RSI) 56.05 58.46
Support Level $25.75 $12.47
Resistance Level $27.63 $13.56
Average True Range (ATR) 0.78 0.54
MACD 0.25 -0.03
Stochastic Oscillator 69.52 54.68

Price Performance

Historical Comparison
MEG
ARVN

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: